Accumulation of presynaptic proteinase K-resistant alpha-synuclein in Parkinson's disease

被引：0
|
作者：
Tanji, Kunikazu [1 ]
Mori, Fumiaki [1 ]
Kakita, Akiyoshi [2 ]
Takahashi, Hitoshi [3 ]
Wakabayashi, Koichi [1 ]
机构：
[1] Hirosaki Univ, Sch Med, Dept Neuropathol, Hirosaki, Aomori 036, Japan
[2] Niigata Univ, Dept Pathol Neurosci, Ctr Bioresource Based Res, Niigata, Japan
[3] Niigata Univ, Dept Pathol, Brain Res Inst, Niigata, Japan
来源：
NEUROSCIENCE RESEARCH | 2010年 / 68卷
关键词：
D O I：
10.1016/j.neures.2010.07.2421
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：E192 / E192
页数：1
相关论文
共 50 条
  • [21] Alpha-synuclein accumulation in glial cells in the brain in Parkinson's disease.
    Yoshimura, N
    BRAIN PATHOLOGY, 2000, 10 (04) : 624 - 624
  • [22] Alpha-synuclein and Parkinson disease
    Hui Liu1
    Neural Regeneration Research, 2007, (04) : 239 - 243
  • [23] Alpha-Synuclein mRNA Is Not Increased in Sporadic PD and Alpha-Synuclein Accumulation Does Not Block GDNF Signaling in Parkinson's Disease and Disease Models
    Su, Xiaomin
    Fischer, D. Luke
    Li, Xin
    Bankiewicz, Krystof
    Sortwell, Caryl E.
    Federoff, Howard J.
    MOLECULAR THERAPY, 2017, 25 (10) : 2231 - 2235
  • [24] Regional distribution of proteinase K-resistant α-synuclein correlates with Lewy body disease stage
    Neumann, M
    Müller, V
    Kretzschmar, HA
    Haass, C
    Kahle, PJ
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2004, 63 (12): : 1225 - 1235
  • [25] Rapamycin attenuates nigral and hippocampal alpha-synuclein accumulation in AAV-mediated alpha-synuclein overexpression model of Parkinson's disease
    Cinar, E.
    Yalcin-Cakmakli, G.
    Ulusoy, A.
    Saka, E.
    Tel, B.
    Elibol, B.
    MOVEMENT DISORDERS, 2021, 36 : S332 - S332
  • [26] Parkinson's Disease, Cortical Dysfunction, and Alpha-Synuclein
    Caviness, John N.
    Lue, Lih-Fen
    Beach, Thomas G.
    Hentz, Joseph G.
    Adler, Charles H.
    Sue, Lucia
    Sadeghi, Ramin
    Driver-Dunckley, Erika
    Evidente, Virgilio G.
    Sabbagh, Marwan N.
    Shill, Holly A.
    Walker, Douglas G.
    MOVEMENT DISORDERS, 2011, 26 (08) : 1436 - 1442
  • [27] Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease
    Fields, Carroll Rutherford
    Bengoa-Vergniory, Nora
    Wade-Martins, Richard
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2019, 12
  • [28] Modeling Parkinson's Disease With the Alpha-Synuclein Protein
    Gomez-Benito, Monica
    Granado, Noelia
    Garcia-Sanz, Patricia
    Michel, Anne
    Dumoulin, Mireille
    Moratalla, Rosario
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [29] Alpha-synuclein and the prion hypothesis in Parkinson's disease
    Melki, R.
    REVUE NEUROLOGIQUE, 2018, 174 (09) : 644 - 652
  • [30] Lipids and alpha-synuclein aggregation in Parkinson's disease
    Broersen, K.
    Davletov, B.
    MOVEMENT DISORDERS, 2007, 22 (12) : VI - VI
12345